Clinical trials
Infertile Females or Females With Ovarian Insufficiency clinical trials
Below are recruiting infertile females or females with ovarian insufficiency clinical trials, each written for real people, not researchers. We’re tracking 166 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07542600Recruiting
Spa therapy to help women with infertility after embryo transfer
This study tests whether spa-based rehabilitation—including thermal water treatments and relaxation therapies—may improve fertility outcomes in women who have had unsuccessful embryo transfers. Researchers hope it might help prepare the body for pregnancy.
Františkovy Lázně, Carlsbad RegionAges 20–40 - NCT06098495Recruiting
Blood test to predict female infertility
This trial looks for a blood test that could help predict infertility in women. If you are between 18 and 43, struggling with infertility or recurrent pregnancy loss, this study may be a fit.
MilanAges 18–43 - NCT07265908Enrolling by invitation
Biobank study for gynecological and fertility conditions
This trial creates a biobank of samples from people with gynecological issues, infertility, or pregnancy problems. It aims to help researchers better understand these conditions and develop future treatments.
Milan, MilanAges Any age - NCT06851754RecruitingPhase 3
Hormone therapy for teens with early menopause
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
Bethesda, MarylandAges 11–19 - NCT07357701Recruiting
Genetic study for unexplained infertility in men and women
This study aims to find genetic causes of certain types of infertility in men and women. If you have been diagnosed with very low sperm count, no sperm, or early ovarian failure, researchers will look at your DNA to discover new genes that might be responsible.
Bethesda, MarylandAges 18–100 - NCT04519151RecruitingPhase 2
Pembrolizumab plus lenvatinib for ovarian cancer that returned
This Phase 2 trial tests whether pembrolizumab plus lenvatinib can shrink ovarian cancer that has come back after platinum chemotherapy. You may be eligible if your cancer returned after a certain “time off” from prior treatment and you meet key health and safety requirements.
Ramat GanAges 18 years+ - NCT07376109Recruiting
Infertility and fertility treatment effects on sexual health
This study looks at how infertility and fertility treatments affect sexual function and behavior. It uses a questionnaire to gather information from women seeking care at a specific fertility center.
Montreal, QuebecAges 18–44 - NCT06539104Recruiting
Artificial intelligence to improve egg and embryo testing in IVF
This trial uses artificial intelligence to assess the quality of eggs and embryos during IVF. It aims to help doctors select the best embryos for transfer, potentially increasing the chance of a successful pregnancy.
PragueAges 18–49 - NCT07509840RecruitingPhase 3
Immune therapy to restore ovary function and fertility
This trial tests whether an immune-modulating drug can restart ovulation and improve fertility in women whose ovaries stopped working due to autoimmune disease. It is for women ages 18–38 with autoimmune premature ovarian insufficiency and certain antibodies.
StockholmAges 18–38 - NCT04948658Recruiting
Freezing ovarian tissue to protect future fertility
This study looks at storing ovarian (ovary) tissue by freezing it for people at higher risk of losing fertility. It may help preserve options for having biological children later, especially for certain genetic conditions, cancer-related risks, or planned gonad removal.
Bethesda, MarylandAges 2–35 - NCT06096766Recruiting
Ovarian function and blood markers study
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
BeijingAges 18–45 - NCT06419127Enrolling by invitation
Embryo time-lapse imaging with genetic testing in IVF
This trial tests whether using a special time-lapse camera to watch embryos develop, together with genetic testing (PGT), can help choose the healthiest embryos for IVF. It may help improve the chances of a successful pregnancy.
Fort Lauderdale, FloridaAges 18–50 - NCT07539844Recruiting
Study of Folate Receptor Alpha in High-Grade Serous Ovarian Cancer
This study examines tissue samples from women with a specific type of ovarian cancer (high-grade serous) to measure how much of a protein called folate receptor alpha is present. Understanding this protein level may help doctors identify which patients could benefit from targeted treatments in the future.
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D.Ages 18 years+ - NCT04419740Recruiting
Mindfulness program for women starting IVF
This study tests whether a mindfulness training program helps women feel better during their first IVF (in vitro fertilization) treatment. If you join, you’ll likely practice mindfulness while you go through IVF, and the team will compare outcomes to those not doing the program.
GenevaAges 18–42 - NCT04866329Recruiting
Study of stress and environmental exposures in IVF fertility
This study looks at how environmental exposures and stress-related “oxidant” changes may affect fertility outcomes in IVF for women. You may be invited if you are in your first IVF egg retrieval cycle and meet the study’s specific IVF setup rules.
ToursAges 18–43 - NCT05567198Recruiting
Testing hormone shots to protect ovaries during lupus chemotherapy
This study looks at whether a monthly/3-month hormone medicine (a “GnRH shot”) can help protect ovaries in people with lupus who are treated with cyclophosphamide. It also compares this to lupus patients who do not receive the ovarian-protecting shot, using questionnaires to track outcomes.
Bethesda, MarylandAges 18–120 - NCT05837325Recruiting
Testing whether AMH levels predict embryo chromosome status
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT05997407Recruiting
Managing stress through mindset for women with infertility
This study tests a mindset-based program to help reduce stress in women dealing with infertility. It is designed for new patients at two specific fertility clinics who have not yet had fertility treatment with a specialist.
Roanoke, VirginiaAges 18–42 - NCT06051201Recruiting
ReceptIVFity test for IVF success prediction
This trial studies a vaginal swab test called ReceptIVFity that looks at the bacteria in your vagina to see if it can help predict how well IVF will work. You can join if you're about to start your first IVF cycle, are not on hormonal birth control or antibiotics, and your IVF is not for emergency reasons.
RotterdamAges 18–42 - NCT06124950Recruiting
Couples program to prevent violence during IVF
This study tests a program to help couples communicate better and reduce stress during IVF, and whether it can prevent intimate partner violence. If you are a couple starting your first or second IVF cycle due to female infertility, you may be eligible to join.
BeijingAges 18 years+ - NCT06459778Recruiting
A new lab method to help eggs develop in IVF for women 35–42
This study is testing a special lab technique called Piezo-ICSI to see if it can improve the chances of a fertilized egg developing normally in women ages 35–42 who are going through IVF or ICSI. It may help if you've had fewer than 3 previous cycles and don’t have certain uterine or genetic issues.
Nanjing, JiangsuAges 35–42 - NCT02741102RecruitingPhase 2/Phase 3
Uterine transplant study for women who cannot get pregnant
This trial tests whether receiving a donated uterus can allow pregnancy in women who cannot become pregnant because of an absent or non-working uterus. It also looks at safety and how well the pregnancy and follow-up medicines work after transplant.
Boston, MassachusettsAges 18–40 - NCT06759337Recruiting
Stress ball or hand holding during IUI for pain and anxiety
This trial tests if using a stress ball or having your hand held during intrauterine insemination (IUI) can reduce pain, anxiety, and discomfort. It compares these two simple comfort techniques to standard care.
Kayseri, MelikgaziAges 18–50 - NCT06863337Recruiting
Glucose patterns in women getting IVF using a glucose monitor
This study uses a continuous glucose monitor to track blood sugar patterns in women undergoing their first or second IVF cycle. It aims to understand how glucose levels may relate to fertility treatments and outcomes.
Shanghai, Shanghai MunicipalityAges 18–40
Hear when a new Infertile Females or Females With Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infertile females or females with ovarian insufficiency?
- Yes. Clin2 currently lists 166 recruiting infertile females or females with ovarian insufficiency studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infertile females or females with ovarian insufficiency trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infertile females or females with ovarian insufficiency trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.